1531 |
Insight from All Data of Left Main Revascularization (MAINCOMPARE, SYNTAX, PRECOMBAT, NOBLE, EXCEL) |
Duk-Woo Park |
Apr. 20. 23 |
1530 |
LM & MVD Revascularization 2023: Guidelines and Beyond |
Sripal Bangalore |
Apr. 20. 23 |
1529 |
Up-to-date TAVR Data from AMC (TP TAVR, ADAPT-TAVR, ASAN TAVR Registry) |
Do-Yoon Kang |
Apr. 20. 23 |
1528 |
Ultra-Minimalist TAVR - Strategies for a Quick Procedure and Short Hospital Stay |
James Flaherty |
Apr. 20. 23 |
1527 |
Coronary Protection in Patients Undergoing TAVI at High Risk of Coronary Occlusion |
Tullio Palmerini |
Apr. 20. 23 |
1526 |
Optimal Indication for CEP for TAVR: Insights from the STS-TVR and PROTECTED-TAVR |
David Joel Cohen |
Apr. 20. 23 |
1525 |
TAVR Techniques in Bicuspid Anatomy – Valve Selection, Sizing, and Positioning |
Jung-Min Ahn |
Apr. 20. 23 |
1524 |
SAVR is Better |
Vinayak Bapat |
Apr. 20. 23 |
1523 |
TAVR is Better |
Eberhard Grube |
Apr. 20. 23 |
1522 |
PROTECTED-TAVR: Statistical or Clinical Interpretation and My Take-Home Messages |
Samir R. Kapadia |
Apr. 20. 23 |